苑东生物:2025年净利润同比增18.89%

Core Viewpoint - The company reported a slight decrease in total revenue for the fiscal year 2025, while net profit showed a significant increase compared to the previous year [2] Financial Performance - The company achieved total operating revenue of 1,331.40 million yuan in 2025, representing a year-on-year decrease of 1.36% [2] - The net profit attributable to the parent company's shareholders was 283.25 million yuan, reflecting a year-on-year growth of 18.89% [2]

EASTONBIOPHARMACEUTICALS-苑东生物:2025年净利润同比增18.89% - Reportify